156 related articles for article (PubMed ID: 24599523)
1. Combining mutations that modulate inter-subunit interactions and proteolytic inactivation enhance the stability of factor VIIIa.
Wakabayashi H; Wintermute JM; Fay PJ
Thromb Haemost; 2014 Jul; 112(1):43-52. PubMed ID: 24599523
[TBL] [Abstract][Full Text] [Related]
2. The role of P4-P3' residues flanking Arg336 in facilitating activated protein C-catalyzed cleavage and inactivation of factor VIIIa.
DeAngelis JP; Varfaj F; Wakabayashi H; Fay PJ
Thromb Res; 2011 Nov; 128(5):470-6. PubMed ID: 21470668
[TBL] [Abstract][Full Text] [Related]
3. Residues surrounding Arg336 and Arg562 contribute to the disparate rates of proteolysis of factor VIIIa catalyzed by activated protein C.
Varfaj F; Wakabayashi H; Fay PJ
J Biol Chem; 2007 Jul; 282(28):20264-72. PubMed ID: 17519239
[TBL] [Abstract][Full Text] [Related]
4. Sequences flanking Arg336 in factor VIIIa modulate factor Xa-catalyzed cleavage rates at this site and cofactor function.
DeAngelis JP; Wakabayashi H; Fay PJ
J Biol Chem; 2012 May; 287(19):15409-17. PubMed ID: 22411993
[TBL] [Abstract][Full Text] [Related]
5. P3-P3' residues flanking scissile bonds in factor VIII modulate rates of substrate cleavage and procofactor activation by thrombin.
Newell-Caito JL; Griffiths AE; Fay PJ
Biochemistry; 2012 Apr; 51(16):3451-9. PubMed ID: 22455313
[TBL] [Abstract][Full Text] [Related]
6. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa.
Pipe SW; Saenko EL; Eickhorst AN; Kemball-Cook G; Kaufman RJ
Blood; 2001 Feb; 97(3):685-91. PubMed ID: 11157485
[TBL] [Abstract][Full Text] [Related]
7. Hemophilia A mutations within the factor VIII A2-A3 subunit interface destabilize factor VIIIa and cause one-stage/two-stage activity discrepancy.
Hakeos WH; Miao H; Sirachainan N; Kemball-Cook G; Saenko EL; Kaufman RJ; Pipe SW
Thromb Haemost; 2002 Nov; 88(5):781-7. PubMed ID: 12428094
[TBL] [Abstract][Full Text] [Related]
8. Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.
Monaghan M; Wakabayashi H; Griffiths AE; Fay PJ
J Thromb Haemost; 2016 May; 14(5):1021-30. PubMed ID: 26878264
[TBL] [Abstract][Full Text] [Related]
9. Enhanced factor VIIIa stability of A2 domain interface variants results from an increased apparent affinity for the A2 subunit. Results from an increased apparent affinity for the A2 subunit.
Monaghan M; Wakabayashi H; Griffiths A; Wintermute J; Fay PJ
Thromb Haemost; 2014 Sep; 112(3):495-502. PubMed ID: 24899227
[TBL] [Abstract][Full Text] [Related]
10. Increasing hydrophobicity or disulfide bridging at the factor VIII A1 and C2 domain interface enhances procofactor stability.
Wakabayashi H; Griffiths AE; Fay PJ
J Biol Chem; 2011 Jul; 286(29):25748-55. PubMed ID: 21628455
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.
Gale AJ; Radtke KP; Cunningham MA; Chamberlain D; Pellequer JL; Griffin JH
J Thromb Haemost; 2006 Jun; 4(6):1315-22. PubMed ID: 16706977
[TBL] [Abstract][Full Text] [Related]
12. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo.
Pipe SW; Eickhorst AN; McKinley SH; Saenko EL; Kaufman RJ
Blood; 1999 Jan; 93(1):176-83. PubMed ID: 9864159
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa.
Pipe SW; Kaufman RJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11851-6. PubMed ID: 9342326
[TBL] [Abstract][Full Text] [Related]
14. Disulfide bond-stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays.
Radtke KP; Griffin JH; Riceberg J; Gale AJ
J Thromb Haemost; 2007 Jan; 5(1):102-8. PubMed ID: 17059431
[TBL] [Abstract][Full Text] [Related]
15. Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex.
Jenkins PV; Freas J; Schmidt KM; Zhou Q; Fay PJ
Blood; 2002 Jul; 100(2):501-8. PubMed ID: 12091341
[TBL] [Abstract][Full Text] [Related]
16. The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential.
Nakajima Y; Oda A; Baatartsogt N; Kashiwakura Y; Ohmori T; Nogami K
Blood Adv; 2024 May; ():. PubMed ID: 38820442
[TBL] [Abstract][Full Text] [Related]
17. Variable contributions of basic residues forming an APC exosite in the binding and inactivation of factor VIIIa.
Takeyama M; Wintermute JM; Manithody C; Rezaie AR; Fay PJ
Biochemistry; 2013 Apr; 52(13):2228-35. PubMed ID: 23480827
[TBL] [Abstract][Full Text] [Related]
18. Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.
Wakabayashi H; Monaghan M; Fay PJ
J Biol Chem; 2014 May; 289(20):14020-9. PubMed ID: 24692542
[TBL] [Abstract][Full Text] [Related]
19. Modification of interdomain interfaces within the A3C1C2 subunit of factor VIII affects its stability and activity.
Wakabayashi H; Fay PJ
Biochemistry; 2013 Jun; 52(22):3921-9. PubMed ID: 23659383
[TBL] [Abstract][Full Text] [Related]
20. Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.
Parker ET; Lollar P
Biochemistry; 2007 Aug; 46(34):9737-42. PubMed ID: 17676877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
